{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T13:16:57Z","timestamp":1774444617684,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier","isbn-type":[{"value":"9780128237618","type":"print"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/b978-0-12-823761-8.00014-8","type":"book-chapter","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T20:59:46Z","timestamp":1663966786000},"page":"435-453","source":"Crossref","is-referenced-by-count":12,"title":["Polypharmacy and medication adherence"],"prefix":"10.1016","author":[{"given":"Marta","family":"Lavrador","sequence":"first","affiliation":[]},{"given":"Ana Cristina","family":"Cabral","sequence":"additional","affiliation":[]},{"given":"Margarida","family":"Castel-Branco","sequence":"additional","affiliation":[]},{"given":"Isabel Vitoria","family":"Figueiredo","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Fernandez-Llimos","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-12-823761-8.00014-8_bib1","series-title":"Adherence to long-term therapies\u2014evidence for action","author":"World Health Organization","year":"2003"},{"issue":"9","key":"10.1016\/B978-0-12-823761-8.00014-8_bib2","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1345\/aph.1D479","article-title":"Development and validation of the medication regimen complexity index","volume":"38","author":"George","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/B978-0-12-823761-8.00014-8_bib3","series-title":"Concordance, adherence and compliance in medicine taking","author":"Horne","year":"2005"},{"issue":"6","key":"10.1016\/B978-0-12-823761-8.00014-8_bib4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0022-3999(99)00057-4","article-title":"Patients\u2019 beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness","volume":"47","author":"Horne","year":"1999","journal-title":"J Psychosom Res"},{"key":"10.1016\/B978-0-12-823761-8.00014-8_bib5","doi-asserted-by":"crossref","first-page":"217047","DOI":"10.1155\/2015\/217047","article-title":"Medication adherence measures: an overview","volume":"2015","author":"Lam","year":"2015","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/B978-0-12-823761-8.00014-8_bib6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/jch.13137","article-title":"Developing an adherence in hypertension questionnaire short version: MUAH-16","volume":"20","author":"Cabral","year":"2018","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"6","key":"10.1016\/B978-0-12-823761-8.00014-8_bib7","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/jep.12773","article-title":"Influence of the mode of administration on the results of medication adherence questionnaires","volume":"23","author":"Cabral","year":"2017","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/B978-0-12-823761-8.00014-8_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ypmed.2017.03.008","article-title":"Medication adherence outcomes of 771 intervention trials: systematic review and meta-analysis","volume":"99","author":"Conn","year":"2017","journal-title":"Prev Med"},{"issue":"3","key":"10.1016\/B978-0-12-823761-8.00014-8_bib9","doi-asserted-by":"crossref","first-page":"e0213432","DOI":"10.1371\/journal.pone.0213432","article-title":"Temporal effectiveness of interventions to improve medication adherence: a network meta-analysis","volume":"14","author":"Wiecek","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/B978-0-12-823761-8.00014-8_bib10","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.18549\/PharmPract.2020.1.1705","article-title":"Guessability of U.S. pharmaceutical pictograms in Iranian prospective users","volume":"18","author":"Saremi","year":"2020","journal-title":"Pharm Pract (Granada)"},{"issue":"5","key":"10.1016\/B978-0-12-823761-8.00014-8_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/11587180-000000000-00000","article-title":"How do the attitudes and beliefs of older people and healthcare professionals impact on the use of multi-compartment compliance aids?: a qualitative study using grounded theory","volume":"28","author":"Nunney","year":"2011","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/B978-0-12-823761-8.00014-8_bib12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"issue":"2","key":"10.1016\/B978-0-12-823761-8.00014-8_bib13","first-page":"203","article-title":"Guidance to manage inappropriate polypharmacy in older people: systematic review and future developments","volume":"16","author":"Stewart","year":"2017","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/B978-0-12-823761-8.00014-8_bib14","series-title":"Polypharmacy management by 2030: a patient safety challenge","author":"Mair","year":"2017"},{"key":"10.1016\/B978-0-12-823761-8.00014-8_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.archger.2016.09.003","article-title":"Inappropriate prescribing in older persons: a systematic review of medications available in different criteria","volume":"68","author":"Lucchetti","year":"2017","journal-title":"Arch Gerontol Geriatr"},{"issue":"2","key":"10.1016\/B978-0-12-823761-8.00014-8_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/jcpt.12246","article-title":"Conceptualizing and measuring potentially inappropriate drug therapy","volume":"40","author":"Santos","year":"2015","journal-title":"J Clin Pharm Ther"},{"issue":"9582","key":"10.1016\/B978-0-12-823761-8.00014-8_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(07)61091-5","article-title":"Appropriate prescribing in elderly people: how well can it be measured and optimised?","volume":"370","author":"Spinewine","year":"2007","journal-title":"Lancet."},{"issue":"4","key":"10.1016\/B978-0-12-823761-8.00014-8_bib18","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4321\/S1886-36552014000400007","article-title":"Defining \u2018elderly\u2019 in clinical practice guidelines for pharmacotherapy","volume":"12","author":"Singh","year":"2014","journal-title":"Pharm Pract (Granada)"},{"issue":"1","key":"10.1016\/B978-0-12-823761-8.00014-8_bib19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","article-title":"Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications","volume":"57","author":"Mangoni","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/B978-0-12-823761-8.00014-8_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0169-409X(02)00172-2","article-title":"Drug efflux transporters in the CNS","volume":"55","author":"Sun","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/B978-0-12-823761-8.00014-8_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/ejhpharm-2016-001044","article-title":"Simpathy consortium. Polypharmacy management programmes: the SIMPATHY project","volume":"24","author":"Mair","year":"2017","journal-title":"Eur J Hosp Pharm"},{"issue":"1","key":"10.1016\/B978-0-12-823761-8.00014-8_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00228-013-1575-8","article-title":"Inappropriate prescribing: a systematic overview of published assessment tools","volume":"70","author":"Kaufmann","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"10.1016\/B978-0-12-823761-8.00014-8_bib23","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0895-4356(92)90144-C","article-title":"A method for assessing drug therapy appropriateness","volume":"45","author":"Hanlon","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"10.1016\/B978-0-12-823761-8.00014-8_bib24","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s40266-013-0118-4","article-title":"The medication appropriateness index at 20: where it started, where it has been, and where it may be going","volume":"30","author":"Hanlon","year":"2013","journal-title":"Drugs Aging"},{"issue":"6","key":"10.1016\/B978-0-12-823761-8.00014-8_bib25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00228-018-2446-0","article-title":"Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria","volume":"74","author":"Motter","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"10.1016\/B978-0-12-823761-8.00014-8_bib26","first-page":"365","article-title":"Preventable drug-related morbidity in older adults 1","volume":"8","author":"Mackinnon","year":"2002","journal-title":"Indic Dev J Manag Care Pharm"},{"issue":"3","key":"10.1016\/B978-0-12-823761-8.00014-8_bib27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/oxfordjournals.intqhc.a002610","article-title":"Preventing drug-related morbidity\u2013determining valid indicators","volume":"14","author":"Morris","year":"2002","journal-title":"Int J Qual Health Care"},{"issue":"2","key":"10.1016\/B978-0-12-823761-8.00014-8_bib28","first-page":"107","article-title":"Preventable drug-related morbidity: determining valid indicators for primary care in Portugal","volume":"20","author":"Guerreiro","year":"2007","journal-title":"Acta Med Port"},{"issue":"4","key":"10.1016\/B978-0-12-823761-8.00014-8_bib29","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"Updated AGS beers criteria for potentially inappropriate medication use in older adults","volume":"67","author":"By the American Geriatrics Society Beers Criteria Update Expert P. American Geriatrics Society 2019","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/B978-0-12-823761-8.00014-8_bib30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2","volume":"44","author":"O\u2019Mahony","year":"2015","journal-title":"Age Ageing"},{"issue":"7","key":"10.1016\/B978-0-12-823761-8.00014-8_bib31","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00228-015-1860-9","article-title":"The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries","volume":"71","author":"Renom-Guiteras","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/B978-0-12-823761-8.00014-8_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40266-017-0514-2","article-title":"The EURO-FORTA (Fit fOR the aged) list: international consensus validation of a clinical tool for improved drug treatment in older people","volume":"35","author":"Pazan","year":"2018","journal-title":"Drugs Aging"},{"issue":"6","key":"10.1016\/B978-0-12-823761-8.00014-8_bib33","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1007\/s11096-019-00920-5","article-title":"Patients\u2019 clinical information requirements to apply the STOPP\/START criteria","volume":"41","author":"Carvalho","year":"2019","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"10.1016\/B978-0-12-823761-8.00014-8_bib34","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s11096-019-00828-0","article-title":"Consequences of ignoring patient diagnoses when using the 2015 updated beers criteria","volume":"41","author":"Lavrador","year":"2019","journal-title":"Int J Clin Pharm"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128237618000148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128237618000148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T23:32:18Z","timestamp":1757028738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128237618000148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780128237618"],"references-count":34,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-823761-8.00014-8","relation":{},"subject":[],"published":{"date-parts":[[2023]]}}}